[Emerging uropathogens: Point for urologists and biologists].

[1]  V. Cattoir,et al.  Recommendations for optimal detection and identification of Actinobaculum schaalii in urine , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  R. Humphries,et al.  In Vitro Antimicrobial Susceptibility of Aerococcus urinae , 2014, Journal of Clinical Microbiology.

[3]  P. Coloby,et al.  Les médicaments antibiotiques en urologie , 2013 .

[4]  L. Lund,et al.  Actinobaculum schaalii, a commensal of the urogenital area , 2013, BJU international.

[5]  M. Rasmussen.  Aerococci and aerococcal infections. , 2013, The Journal of infection.

[6]  N. Ritz,et al.  Actinobaculum schaalii an emerging pediatric pathogen? , 2012, BMC Infectious Diseases.

[7]  M. Rasmussen,et al.  Clinical and microbiological features of bacteraemia with Aerococcus urinae. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  K. Søby,et al.  Actinobaculum schaalii, a cause of urinary tract infections in children? , 2012, Acta paediatrica.

[9]  U. S. Justesen,et al.  Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Analysis of Gram-Positive, Catalase-Negative Cocci Not Belonging to the Streptococcus or Enterococcus Genus and Benefits of Database Extension , 2012, Journal of Clinical Microbiology.

[10]  V. Cattoir.  Actinobaculum schaalii: review of an emerging uropathogen. , 2012, The Journal of infection.

[11]  L. Lund,et al.  Actinobaculum schaalii in urological patients, screened with real-time polymerase chain reaction , 2011, Scandinavian journal of urology and nephrology.

[12]  S. Tschudin-Sutter,et al.  Actinobaculum schaalii - invasive pathogen or innocent bystander? A retrospective observational study , 2011, BMC infectious diseases.

[13]  K. Søby,et al.  In vitro susceptibility of Actinobaculum schaalii to mecillinam. , 2011, The Journal of antimicrobial chemotherapy.

[14]  Robin Patel,et al.  Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae. , 2011, Diagnostic microbiology and infectious disease.

[15]  K. Jaton,et al.  Actinobaculum schaalii: clinical observation of 20 cases. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  A. F. Yassin,et al.  Comparative chemotaxonomic and phylogenetic studies on the genus Arcanobacterium Collins et al. 1982 emend. Lehnen et al. 2006: proposal for Trueperella gen. nov. and emended description of the genus Arcanobacterium. , 2011, International journal of systematic and evolutionary microbiology.

[17]  Gilbert GREUB,et al.  In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance. , 2010, The Journal of antimicrobial chemotherapy.

[18]  Patrick Legrand,et al.  Aerococcus urinae and Aerococcus sanguinicola, two frequently misidentified uropathogens , 2010, Scandinavian journal of infectious diseases.

[19]  M. Mörgelin,et al.  Platelet Activation and Biofilm Formation by Aerococcus urinae, an Endocarditis-Causing Pathogen , 2010, Infection and Immunity.

[20]  M. D. de Jong,et al.  Aerococcus urinae: Severe and Fatal Bloodstream Infections and Endocarditis , 2010, Journal of Clinical Microbiology.

[21]  K. Søby,et al.  Actinobaculum schaalii, a Common Uropathogen in Elderly Patients, Denmark , 2010, Emerging infectious diseases.

[22]  J. Clarridge,et al.  Site and Clinical Significance of Alloscardovia omnicolens and Bifidobacterium Species Isolated in the Clinical Laboratory , 2009, Journal of Clinical Microbiology.

[23]  S. Corvec,et al.  A case of osteitis due to Staphylococcus aureus and Arcanobacterium bernardiae coinfection. , 2009, Diagnostic microbiology and infectious disease.

[24]  L. Zoitopoulos,et al.  Isolation and Identification of Bifidobacteriaceae from Human Saliva , 2008, Applied and Environmental Microbiology.

[25]  H. Schønheyder,et al.  Six cases of Aerococcus sanguinicola infection: Clinical relevance and bacterial identification , 2008, Scandinavian journal of infectious diseases.

[26]  R. Fader,et al.  Clinical significance of Aerococcus urinae: a retrospective review. , 2005, Diagnostic microbiology and infectious disease.

[27]  N. Højlyng,et al.  Ten Cases of Actinobaculum schaalii Infection: Clinical Relevance, Bacterial Identification, and Antibiotic Susceptibility , 2005, Journal of Clinical Microbiology.

[28]  R. Heller,et al.  Urinary tract infection due toArcanobacterium bernardiae in a patient with a urinary tract diversion , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[29]  A. Buiting,et al.  Urinary tract infections withAerococcus urinae in the South of the Netherlands , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[30]  G. Tyrrell,et al.  Phenotypic Description and Antimicrobial Susceptibilities of Aerococcus sanguinicola Isolates from Human Clinical Samples , 2003, Journal of Clinical Microbiology.

[31]  R. Skov,et al.  In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. , 2001, The Journal of antimicrobial chemotherapy.

[32]  K. Carroll,et al.  Septic arthritis due to Arcanobacterium bernardiae in an immunocompromised patient. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  P. Lawson,et al.  Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. , 1997, International journal of systematic bacteriology.

[34]  H. Goossens,et al.  Severe infection due to Actinomyces bernardiae: case report. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.